Stanford Accelerated Recovery Trial (START)
The goal of this study is to determine whether administering Gabapentin prior to surgery affects duration of pain and opioid use post-surgery. The investigators aim to compare gabapentin to placebo in a prospective, randomized clinical trial in which patients will be followed post-surgery until pain resolves and opioid use ceases.
Stanford is not currently accepting new patients for this trial. You may want to check clinicaltrials.gov to see if other locations are recruiting.
- drug : Placebo
- drug : Gabapentin
Phase: Phase 3
Ages Eligible For Study:
1. Age 18-75 2. Undergoing a scheduled surgery 3. English speaking 4. Ability and willingness to complete questionnaires or use palm pilot